Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Sayaka Ueno"'
Autor:
Kosuke Hamai MD, PhD, Ryo Katsura MD, Shinya Miyake MD, Suguru Fujita MD, Shinpei Tada MD, Tetsu Hirakawa MD, Sayaka Ueno MD, Takuya Tanimoto MD, PhD, Nobuhisa Ishikawa MD, PhD
Publikováno v:
Cancer Control, Vol 31 (2024)
Introduction Docetaxel plus ramucirumab (DTX + RAM) therapy is a standard treatment for previously treated lung cancer, but many adverse events have been reported. This retrospective study was conducted to examine if the side effects of DTX + RAM the
Externí odkaz:
https://doaj.org/article/d73842c03f88488690add78a116e86b0
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-16 (2022)
Endogenously expressed pigment epithelium–derived factor (PEDF) promotes increased survival of ovarian cancer cells in the peritoneal cavity by inducing IL-10 expression in CD206 + peritoneal macrophages.
Externí odkaz:
https://doaj.org/article/117bbabc929244e3999bab4e510dcab5
Publikováno v:
The Journal of Reproduction and Development, Vol 68, Iss 5, Pp 335-339 (2022)
Intracytoplasmic sperm injection (ICSI) is an alternative technique to in vitro fertilization (IVF) for producing transferable blastocysts, especially in combination with cryopreserved oocytes, when the IVF system does not work sufficiently. The pres
Externí odkaz:
https://doaj.org/article/b7bd851c669b43f292636faa75fdd5d0
Autor:
Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki, Kosuke Hamai, Naoko Matsumoto, Mirai Matsumura, Shoko Isoyama, Sayaka Ueno, Mineyo Mito, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Reo Kawano, Ken Masuda, Ryohei Nishino, Nobuhisa Ishikawa, Masahiro Yamasaki, Noboru Hattori
Publikováno v:
Thoracic Cancer, Vol 13, Iss 11, Pp 1611-1618 (2022)
Abstract Background Pembrolizumab is the recommended first‐line therapy for patients with advanced non‐small‐cell lung cancer (NSCLC) and a programmed death ligand‐1 (PD‐L1) tumor proportion score (TPS) of ≥50% without driver mutations. H
Externí odkaz:
https://doaj.org/article/df1f1b43964e4f4284aa4d4a97baabef
Autor:
Kosuke Hamai, Shinya Miyaka, Shinpei Tada, Suguru Fujita, Tetsu Hirakawa, Mirai Matsumura, Sayaka Ueno, Takuya Tanimoto, Nobuhisa Ishikawa
Publikováno v:
Cancer Reports, Vol 6, Iss 4, Pp n/a-n/a (2023)
Abstract Background Pegfilgrastim is recommended in docetaxel plus ramucirumab (DTX + RAM) therapy for recurrent nonsmall cell lung cancer (NSCLC) because of the associated frequency of febrile neutropenia (FN). However, the FN occurs less frequently
Externí odkaz:
https://doaj.org/article/9bbb937f0fdb497bb48a3030a5bba9c7
Autor:
Kosuke Hamai, Hiroki Tanahashi, Sayaka Ueno, Hanae Konishi, Mirai Matsumura, Akio Nomura, Kanako Nakamoto, Shoko Isoyama, Takuya Tanimoto, Hiroyasu Shoda, Nobuhisa Ishikawa
Publikováno v:
Thoracic Cancer, Vol 11, Iss 6, Pp 1716-1719 (2020)
A 90‐year‐old female was admitted to our hospital with a history of a dry cough. Chest computed tomography (CT) scan showed a tumor shadow, and CT‐guided lung biopsy revealed squamous cell carcinoma harboring an EGFR mutation. In addition, prog
Externí odkaz:
https://doaj.org/article/689310ba3a2a4976860bb1fa84fbe589
Autor:
Takuya Tanimoto, Mirai Matsumura, Shinpei Tada, Suguru Fujita, Sayaka Ueno, Kosuke Hamai, Takuji Omoto, Hiroyuki Maeda, Takashi Nishisaka, Nobuhisa Ishikawa
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 54, Iss 3, Pp 534-535 (2021)
Externí odkaz:
https://doaj.org/article/87983dde008f4688856b83a9483fb434
Autor:
HARUNA NAKAMURA, SACHIKO MIZUMOTO, HIROKAZU TANINO, YUI NIWA, MITSUTOSHI OGINO, YOKO SAKODA, KAZUHIKO TSUCHIYA, SEISHI KONO, MUNEHARU KONISHI, SAYAKA UENO, TOMONARI KUNIHISA
Publikováno v:
Cancer Diagnosis & Prognosis; May/Jun2024, Vol. 4 Issue 3, p309-314, 6p
Autor:
Tetsu Hirakawa, Takuya Tanimoto, Yui Hattori, Ryo Katsura, Shinya Miyake, Suguru Fujita, Sayaka Ueno, Ken Masuda, Takashi Nishisaka, Nobuhisa Ishikawa
Publikováno v:
Internal Medicine; 2024, Vol. 54 Issue 7, p979-983, 5p
Autor:
Shoko, Isoyama, Nobuhisa, Ishikawa, Kosuke, Hamai, Mirai, Matsumura, Hiroki, Kobayashi, Akio, Nomura, Sayaka, Ueno, Takuya, Tanimoto, Hiroyuki, Maeda, Hiroshi, Iwamoto, Noboru, Hattori
Publikováno v:
Internal Medicine. 61:1663-1671
Objective Switching from mepolizumab to benralizumab has been reported to significantly improve both asthma control and the lung function. However, the data on its efficacy in elderly patients with severe eosinophilic asthma are limited. This study a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbdd373525e18248424ad84cea4987ce
https://doi.org/10.2169/internalmedicine.8180-21
https://doi.org/10.2169/internalmedicine.8180-21